Literature DB >> 15606696

The association of smoking and subclinical atherosclerosis in Type 2 diabetes: modification by duration of diabetes.

R Karim1, T A Buchanan, H N Hodis, Y Li, W J Mack.   

Abstract

BACKGROUND: Diabetes is a relatively common disease in the United States, and cardiovascular disease is the major cause of morbidity and mortality among persons with diabetes. While smoking is one of the most well-established risk factors for heart disease and atherosclerosis, the effect of smoking on atherosclerosis among diabetic patients has not been thoroughly investigated. The primary objective of this paper was to evaluate the impact of smoking on atherosclerosis among Type 2 diabetic patients and to evaluate whether smoking associations with atherosclerosis are modified by diabetes-related variables.
METHODS: We used cross-sectional baseline data from a randomized controlled trial to evaluate the associations between smoking and common carotid artery intima-media thickness (IMT) in 299 subjects with Type 2 diabetes. There were 34 (11%) current cigarette smokers, 73 (24%) former cigarette smokers, and 192 (64%) subjects who had never smoked regularly.
RESULTS: There was an increasing trend in mean carotid IMT with both longer duration and increased frequency of smoking (adjusted P for trend 0.04 and 0.02, respectively). The mean +/- SE carotid IMT was non-significantly thicker (0.872 +/- 0.01 mm) in diabetic patients who had ever smoked than never smokers (0.842 +/- 0.01 mm) after controlling for age, gender and other potential confounders (P = 0.08). The negative effects of ever smoking (P = 0.01 for interaction), number of cigarettes smoked daily (P = 0.003 for interaction) and duration of smoking (P = 0.03 for interaction) on carotid IMT were accentuated with longer duration of diabetes.
CONCLUSION: Smoking is associated with subclinical atherosclerosis in diabetic persons and interacts with duration of diabetes to accentuate atherosclerosis. The association between carotid IMT and duration of diabetes increases with both the frequency and duration of smoking.

Entities:  

Mesh:

Year:  2005        PMID: 15606696     DOI: 10.1111/j.1464-5491.2004.01353.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

Review 1.  Cardiovascular risk assessment in type 2 diabetes mellitus.

Authors:  Ebaa Al-Ozairi; R Jan-Willem Middelbeek; Edward S Horton
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 2.  Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.

Authors:  Jia Liu; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2019-10-09

3.  Role of diabetes, hypertension, and cigarette smoking on atherosclerosis.

Authors:  Ram K Mathur
Journal:  J Cardiovasc Dis Res       Date:  2010-04

4.  Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes study.

Authors:  Andrew J Karter; Mark R Stevens; Edward W Gregg; Arleen F Brown; Chien-Wen Tseng; David G Marrero; O Kenrik Duru; Tiffany L Gary; John D Piette; Beth Waitzfelder; William H Herman; Gloria L Beckles; Monika M Safford; Susan L Ettner
Journal:  Am J Public Health       Date:  2007-06-28       Impact factor: 9.308

5.  Ambient air pollution and atherosclerosis in Los Angeles.

Authors:  Nino Künzli; Michael Jerrett; Wendy J Mack; Bernardo Beckerman; Laurie LaBree; Frank Gilliland; Duncan Thomas; John Peters; Howard N Hodis
Journal:  Environ Health Perspect       Date:  2005-02       Impact factor: 9.031

6.  Cumulative effects of hypertension, dyslipidemia, and chronic kidney disease on carotid atherosclerosis in Chinese patients with type 2 diabetes mellitus.

Authors:  Chuang Yuan; Christopher W K Lai; Lawrence W C Chan; Meyrick Chow; Helen K W Law; Michael Ying
Journal:  J Diabetes Res       Date:  2014-04-22       Impact factor: 4.011

Review 7.  Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.

Authors:  Jia Liu; Lu-Ning Wang
Journal:  Cochrane Database Syst Rev       Date:  2017-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.